Endocrinology, Vol 136, 106-115, Copyright © 1995 by Endocrine Society

ARTICLES

Targeted overexpression of an inactive calmodulin that binds Ca2+ to the mouse pancreatic beta-cell results in impaired secretion and chronic hyperglycemia

TJ Ribar, PN Epstein, PA Overbeek and AR Means
Department of Pharmacology, Duke University, Durham, North Carolina 27710.

We have previously reported that elevated levels of calmodulin in pancreatic beta-cells of mice resulted in a unique secretory defect. To determine if this effect was due to Ca2+ buffering, a mutant form of calmodulin that has an eight-amino acid deletion in the central helix (CaM-8) was used. The mutated calmodulin binds Ca2+ normally, but alters the ability to interact with known Ca2+/calmodulin-activated enzymes. In vitro competition analysis using HIT cell extracts verified that in the presence of Ca2+, CaM-8 exhibited at least a 100-fold lower affinity for calmodulin-binding proteins than did normal CaM in this model beta-cell. Transgenic mice were then generated by targeting the CaM-8 to pancreatic beta-cells. The CaM-8 mice were normoglycemic at birth, but developed a hyperglycemic condition starting at about 6 days of age. This condition was progressive and characterized by elevated blood glucose that coincided with reduced levels of pancreatic insulin and low circulating serum insulin levels. Hormone measurements and immunohistochemical analysis revealed that islets exhibited a nonimmune reduction of insulin immunoreactive beta-cells, reduced amounts of insulin, and a 5-fold higher level of CaM-8 protein relative to normal CaM protein. Perifusion assays were used to test the secretion response to glucose. CaM-8 islets demonstrated a reduction in first and second phase insulin secretion, which became progressively worse with age. Depolarization of the membrane with 50 mM K+ in the presence of high glucose did not significantly improve secretion. Carbachol, which is thought to act in beta-cells through the release of intracellular Ca2+ stores and activation of protein kinase-C, restored both phases of secretion to normal levels. These results suggest that disruption of intracellular Ca2+ homeostasis alone is sufficient to interfere with the insulin secretion pathway.

This article has been cited by other articles:

				S.-N. Yang and P.-O. Berggren The Role of Voltage-Gated Calcium Channels in Pancreatic {beta}-Cell Physiology and Pathophysiology Endocr. Rev., October 1, 2006; 27(6): 621 - 676. [Abstract] [Full Text] [PDF]

				S. Tsunekawa, Y. Miura, N. Yamamoto, Y. Itoh, Y. Ariyoshi, T. Senda, Y. Oiso, and I. Niki Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice Eur. J. Endocrinol., May 1, 2005; 152(5): 805 - 811. [Abstract] [Full Text] [PDF]

				C. G. Nichols and J. C. Koster Diabetes and insulin secretion: whither KATP? Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E403 - E412. [Abstract] [Full Text] [PDF]

				K. Sooy, T. Schermerhorn, M. Noda, M. Surana, W. B. Rhoten, M. Meyer, N. Fleischer, G. W. G. Sharp, and S. Christakos Calbindin-D28k Controls [Ca2+]i and Insulin Release. EVIDENCE OBTAINED FROM CALBINDIN-D28k KNOCKOUT MICE AND beta CELL LINES J. Biol. Chem., November 26, 1999; 274(48): 34343 - 34349. [Abstract] [Full Text] [PDF]

				P. M. Jones and S. J. Persaud Protein Kinases, Protein Phosphorylation, and the Regulation of Insulin Secretion from Pancreatic {beta}-Cells. Endocr. Rev., August 1, 1998; 19(4): 429 - 461. [Abstract] [Full Text] [PDF]

				D. B. Zimmer, J. Chessher, G. L. Wilson, and W. E. Zimmer S100A1 and S100B Expression and Target Proteins in Type I Diabetes Endocrinology, December 1, 1997; 138(12): 5176 - 5183. [Abstract] [Full Text] [PDF]

				K. A. Anderson, T. J. Ribar, M. Illario, and A. R. Means Defective Survival and Activation of Thymocytes in Transgenic Mice Expressing a Catalytically Inactive Form of Ca2+/Calmodulin-Dependent Protein Kinase IV Mol. Endocrinol., June 1, 1997; 11(6): 725 - 737. [Abstract] [Full Text]

				S. H. Lee, H. Y. Seo, J. C. Kim, W. D. Heo, W. S. Chung, K. J. Lee, M. C. Kim, Y. H. Cheong, J. Y. Choi, C. O. Lim, et al. Differential Activation of NAD Kinase by Plant Calmodulin Isoforms. THE CRITICAL ROLE OF DOMAIN I J. Biol. Chem., April 4, 1997; 272(14): 9252 - 9259. [Abstract] [Full Text] [PDF]

				C.-R. Jan, T. J. Ribar, A. R. Means, and G. J. Augustine Alterations in Calcium Channel Currents Underlie Defective Insulin Secretion in a Transgenic Mouse J. Biol. Chem., June 28, 1996; 271(26): 15478 - 15485. [Abstract] [Full Text] [PDF]

				T. J. Ribar, C.-R. Jan, G. J. Augustine, and A. R. Means Defective Glycolysis and Calcium Signaling Underlie Impaired Insulin Secretion in a Transgenic Mouse J. Biol. Chem., December 1, 1995; 270(48): 28688 - 28695. [Abstract] [Full Text] [PDF]